Senate Plans Legislation to Prepare for Next Pandemic Like COVID-19

June 23, 2020 by Tom Ramstack
Sen. Lamar Alexander (R-Tenn.) talks with reporters on Nov. 29, 2016, before the Senate Policy Luncheons in the U.S. Capitol. (Tom Williams/Congressional Quarterly/Newscom/Zuma Press/TNS)

WASHINGTON — The U.S. Senate tried Tuesday to respond to warnings from infectious disease experts that coronavirus is only an example of other pandemics that are coming soon.

The World Health Organization has warned that a global population topping 7.8 billion plus global warming are creating a breeding ground for the kind of viruses that can devastate people and economies.

The Senate Health, Education, Labor and Pensions Committee wants to use coronavirus as an incubator for ideas to prepare for the next pandemic.

“COVID 19 has exposed some gaps,” Sen. Lamar Alexander, R-Tenn., said during a hearing Tuesday about the nation’s preparations for the pandemic.

He gave a glimpse of a bill the committee he chairs is putting together for introduction in the Senate soon.

It would provide funding to accelerate research and development on vaccines, expand a network for early detection of outbreaks, stockpile medicines and personal protective equipment and assist states in responding to diseases.

Alexander said Congress should “pass legislation this year to be prepared for the next pandemic that will surely come.”

Many provisions of the bill he is overseeing are derived from a plan proposed 15 years ago by former Senate Majority Leader Bill Frist, who was a witness at the hearing Tuesday.

Frist called his plan the “Manhattan Project of the 21st Century,” which is taken from the name of the World War II project to develop a nuclear bomb.

“Most of what I recommended in 2005 remains undone,” Frist told the Senate committee.

He suggested that new disease prevention and response programs be funded from the U.S. defense budget. This year’s fiscal year defense budget is $721.5 billion.

“Health security is national security,” Frist said.

He also recommended more public-private partnerships to manufacture the medical equipment needed for pandemic responses.

Julie L. Gerberding, chief patient officer for pharmaceutical giant Merck & Co., said the federal government must be willing to pursue research and development for new disease-fighting technologies even if there is no certainty of success.

“If we aim for efficiency, we’re going to be slow and miss the boat,” Gerberding said.

She mentioned the federal government’s Biomedical Advanced Research and Development Authority (BARDA) as an organization that could take the lead in research and development.

On Tuesday, BARDA announced the latest of several public-private ventures to develop a rapid COVID-19 test. The technology from MBio Diagnostics uses blood flowing through a cartridge to measure antibodies that indicate the presence of disease in as little as five minutes.

BARDA also is working to develop vaccines, medicines and infection control equipment.

The hearing took place as the number of reported coronavirus cases hit record levels in 23 states this week. Nationwide, 2.3 million cases have been reported with more than 120,000 deaths.

One of the states hardest hit is Texas, where disease experts this week accused the federal government of a slow response to the outbreak.

“What’s next,” asked Gerald Parker, director of the pandemic and biosecurity program at Texas A&M’s Bush School of Public Service, during a televised interview. “We must prevent this from happening again. COVID-19 is not a 100 year event like some people are saying.”

At a separate U.S. House hearing Tuesday, Anthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases, said states are opening too soon to avoid a resurgence of the disease.

Although deaths from the virus have been dropping in the past few days, the number of infections is going up.

“Deaths always lag considerably behind cases,” he said.

Health

Trump's Rushmore Trip Draws Real and Figurative Fireworks
Political News
Trump's Rushmore Trip Draws Real and Figurative Fireworks

SIOUX FALLS, S.D. (AP) — President Donald Trump will begin his Independence Day weekend on Friday with a patriotic display of fireworks at Mount Rushmore before a crowd of thousands, but even in a part of the country where many remain supportive of the president, the... Read More

Virus Concerns Grow — As Do Crowds Flocking to Jersey Shore
Health
Virus Concerns Grow — As Do Crowds Flocking to Jersey Shore

BELMAR, N.J. (AP) — As coronavirus-related restrictions are eased and temperatures climb, people are flocking back to the Jersey Shore. And with the July Fourth holiday weekend upon us, that's making some people nervous, particularly given the large crowds that have surfaced at some popular shore... Read More

Democrats Say US Needs to Address Protective Gear Shortage
Health
Democrats Say US Needs to Address Protective Gear Shortage

A congressional committee criticized President Donald Trump’s administration on Thursday for a series of problems in distributing personal protective and testing equipment during the coronavirus pandemic and called on the administration to come up with a better plan. “We need urgent action from the federal government... Read More

From Big Cities to Backyards, July 4 Not Usual Blowout Bash
In The News
From Big Cities to Backyards, July 4 Not Usual Blowout Bash

NEW YORK (AP) — The idea sounds almost un-American. The Fourth of July was always a time for communities to come together, daylong celebrations with patriotic parades in the morning and fireworks finales to cap it off. This year, people are being urged to stay home.... Read More

Fauci Warns US Needs to Reverse COVID-19 Trends
Health
Fauci Warns US Needs to Reverse COVID-19 Trends

WASHINGTON — The nation’s top infectious disease specialist warned Tuesday that the United States could see up to 100,000 new cases per day of the virus that causes COVID-19 if the nation does not take steps to control the pandemic. Anthony Fauci, the director of the... Read More

FDA Issues Guidance on Development of a Safe and Effective COVID-19 Vaccine
Health
FDA Issues Guidance on Development of a Safe and Effective COVID-19 Vaccine
June 30, 2020
by Dan McCue

WASHINGTON - The U.S. Food and Drug Administration released a series of recommendations Tuesday that it say should help facilitate the timely development of a safe and effective COVID-19 vaccine. The agency said the guidance reflects advice it has been providing over the "past several months"... Read More

News From The Well
scroll top